<DOC>
	<DOCNO>NCT02263040</DOCNO>
	<brief_summary>The objective pilot study assess immunogenicity reactogenicity Fluzone High Dose Fluzone ( standard adult dose ) influenza vaccine healthcare worker .</brief_summary>
	<brief_title>A Pilot Study Assess Immunogenicity Reactogenicity High Versus Standard Dose TIV</brief_title>
	<detailed_description>This prospective , randomize control , observer blind trial HDTIV ( Fluzone High Dose trivalent inactivate influenza vaccine ) versus SDTIV ( Fluzone , standard dose TIV ) 100 healthcare worker 18-64 year age . Participants receive , 1:1 ratio , one dose either SDTIV HDTIV contain strain influenza virus recommend World Health Organization season recruitment . All adverse event collect 7 day follow injection , serious adverse event collect day 21 , serum antibody test obtain day 0 day 21 . The primary outcome seroconversion strain vaccine include vaccine , measure change HAI titer day 0 day 21 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . 1864 year old , inclusive , October 1st year enrolment ; 2 . Healthcare worker , broadly define person either provide health care , work acute care hospital long term healthcare facility ; 3 . Has access email internet adverse event reporting , willing complete form paper deliver site study office ; 4 . Understand study , agree requirement , give write consent ; 1 . Receipt influenza vaccine current northern hemisphere season prior randomization ; 2 . Serious adverse event previous dose influenza vaccine ; 3 . IgE mediate allergic reaction previous dose influenza vaccine excipients study vaccine 4 . Previous episode GuillainBarré syndrome 6 week receive influenza vaccine ; 5 . Receipt immunoglobulin , blood bloodderived product past 3 month ; 6 . Receipt another vaccine , initiation new medication , hospital admission reason within 30 day prior study dose vaccine 7 . Plans receive vaccine , initiate medication , admitted hospital day 21 vaccination ( visit 2 ) ; 8 . Known suspected congenital acquire immunodeficiency ( include HIV infection ) ; receipt immunosuppressive therapy , anticancer chemotherapy radiation therapy , within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) 9 . Any condition , include limited drug alcohol addiction , , opinion investigator might interfere ability comply trial conduct completion ; 10 . Moderate severe acute illness active infection fever ( temperature ≥37.8oC ) day vaccine dose due ( participant may receive dose vaccine 48 hour symptom resolve body temperature return normal without use antipyretic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>influenza vaccine</keyword>
	<keyword>adult</keyword>
	<keyword>immunogenicity</keyword>
	<keyword>reactogenicity</keyword>
</DOC>